In the early stage of tumorigenesis, the TGF-β signaling pathway can inhibit tumor proliferation, while in the late stage of the tumor, a persistently elevated or abnormally transduced TGF-β signaling pathway may lead to tumor proliferation and metastasis (105). This evidence concerns the gene TGFB1 and neoplasm.